We just received data on a new analyst forecast for $JANX. Kaveri Pohlman from Clear Street set a price target of 12.0 for JANX.
To track analyst ratings and price targets for $JANX, check out Quiver Quantitative's $JANX forecast page.
Should you buy $JANX?
Some analysts are better than others. To view the past performance of Clear Street, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$JANX Price Targets
Multiple analysts have issued price targets for $JANX recently. We have seen 9 analysts offer price targets for $JANX in the last 6 months, with a median target of $45.0.
Here are some recent targets:
- Kaveri Pohlman from Clear Street set a target price of $12.0 on 01/20/2026
- Kelsey Goodwin from Piper Sandler set a target price of $30.0 on 01/16/2026
- Etzer Darout from Barclays set a target price of $29.0 on 12/17/2025
- Swayampakula Ramakanth from HC Wainwright & Co. set a target price of $45.0 on 12/02/2025
- Bradley Canino from Stifel set a target price of $38.0 on 12/02/2025
- Geoff Meacham from B of A Securities set a target price of $49.0 on 12/02/2025
- Josh Schimmer from Cantor Fitzgerald set a target price of $150.0 on 12/02/2025
$JANX Insider Trading Activity
$JANX insiders have traded $JANX stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $JANX stock by insiders over the last 6 months:
- ANDREW HOLLMAN MEYER (Chief Business Officer) has made 0 purchases and 5 sales selling 25,210 shares for an estimated $736,704.
- DAVID ALAN CAMPBELL (President and CEO) sold 8,072 shares for an estimated $110,828
- ZACHARIAH MCIVER (Chief Medical Officer) sold 2,714 shares for an estimated $37,263
- THOMAS DIRAIMONDO (Chief Scientific Officer) sold 2,505 shares for an estimated $34,393
- CHARLES M. WINTER (Chief Technical Officer) sold 2,401 shares for an estimated $32,965
- MARIA DOBEK (Vice President, Accounting) sold 1,462 shares for an estimated $20,073
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$JANX Hedge Fund Activity
We have seen 79 institutional investors add shares of $JANX stock to their portfolio, and 85 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ECOR1 CAPITAL, LLC removed 1,469,818 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $35,922,351
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 972,691 shares (+inf%) to their portfolio in Q3 2025, for an estimated $23,772,568
- CORMORANT ASSET MANAGEMENT, LP removed 650,000 shares (-43.3%) from their portfolio in Q3 2025, for an estimated $15,886,000
- ORBIMED ADVISORS LLC added 555,800 shares (+45.9%) to their portfolio in Q3 2025, for an estimated $13,583,752
- PRICE T ROWE ASSOCIATES INC /MD/ removed 527,871 shares (-29.4%) from their portfolio in Q3 2025, for an estimated $12,901,167
- STATE STREET CORP added 503,357 shares (+36.3%) to their portfolio in Q3 2025, for an estimated $12,302,045
- TANG CAPITAL MANAGEMENT LLC added 500,000 shares (+250.0%) to their portfolio in Q3 2025, for an estimated $12,220,000
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
